GSA Capital Partners’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.46M Sell
156,486
-11,078
-7% -$78.8K 0.09% 327
2026
Q2
$908K Buy
167,564
+77,651
+86% +$357K 0.06% 571
2026
Q1
$339K Buy
+89,913
New +$485K 0.02% 1177
2025
Q2
– Sell
-52,646
Closed -$126K – 2102
2025
Q1
$126K Buy
52,646
+5,679
+12% +$16K 0.01% 1472
2024
Q4
$171K Buy
46,967
+25,453
+118% +$116K 0.01% 1449
2024
Q3
$136K Buy
+21,514
New +$145K 0.01% 1459
2023
Q4
– Sell
-20,386
Closed -$69K – 1883
2023
Q3
$69K Sell
20,386
-242
-1% -$1.59K 0.01% 1404
2023
Q2
$171K Buy
20,628
+8,770
+74% +$79K 0.02% 1311
2023
Q1
$104K Buy
+11,858
New +$132K 0.01% 1351
2022
Q4
– Sell
-45,712
Closed -$290K – 1842
2022
Q3
$290K Buy
45,712
+21,910
+92% +$185K 0.04% 955
2022
Q2
$214K Buy
+23,802
New +$209K 0.03% 1041

Other funds holding SGHT

GSA Capital Partners's SGHT Position: Q3 2026 in Review

GSA Capital Partners reduced its Sight Sciences (SGHT) stake by 6.6% in Q3 2026, selling an estimated $78.8K and leaving 156,486 shares worth $1.46M. The position accounts for 0.09% of the portfolio, ranked #327.

GSA Capital Partners first reported a position in SGHT in Q2 2022 and has held it in 11 quarters since. 131 funds tracked by Wall St. Rank hold SGHT as of Q3 2026.

  • GSA Capital Partners held 156,486 shares of Sight Sciences worth $1.46M as of Q3 2026.
  • GSA Capital Partners sold 11,078 Sight Sciences shares in Q3 2026, an estimated $78.8K.
  • Sight Sciences made up 0.09% of GSA Capital Partners's portfolio in Q3 2026, its #327 holding.
  • GSA Capital Partners first reported a position in Sight Sciences in Q2 2022 and has held it in 11 quarters since.
  • 131 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.